在患有帕金森病,携带GBA1变体的患者的亚体质核深脑刺激后,运动和认知结果
Hikaru Kamo1,2, Genko Oyama1,3, Mai Shimizu1
1Department of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Movement disorders clinical practice
|November 13, 2025
概括
这项研究发现,在帕金森病患者中,GBA1变异在亚thalamic核深脑刺激 (STN-DBS) 后不会显著影响运动或认知结果. 然而,GBA1载体在5年后在药物OFF状态下表现出更糟糕的运动症状.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 深度大脑刺激 (DBS) 是帕金森病 (PD) 的关键治疗方法.
- DBS的有效性可能受到遗传因素的影响,包括GBA1变异.
- GBA1变异与PD风险增加和脑下丘脑下核DBS (STN-DBS) 后认知衰退有关.
研究的目的:
- 为了研究GBA1变异和帕金森病患者接受STN-DBS的结果之间的关系.
- 评估GBA1变异对双边STN-DBS后的运动,认知和药物状态的影响.
主要方法:
- 在STN-DBS后5年内对371名帕金森病患者进行了回顾性分析.
- 基因评估GBA1变体和临床评估在基线和后续点.
- 倾向性得分匹配和线性混合效应模型用于分析纵向结果.
主要成果:
- 随着时间的推移,GBA1变体携带者和非携带者之间的运动或认知评估没有显著差异.
- 在手术后5年,GBA1载体在药物OFF状态下经历了运动症状的恶化.
- 在这两组患者中,认知功能保持稳定,所有患者的利沃多巴相当剂量 (LEDD) 均下降.
结论:
- 在帕金森病的STN-DBS之后,GBA1变异可能不会显著改变运动或认知轨迹.
- 这一发现是基于日本最大的STN-DBS的PD遗传队列.
- 建议进行进一步的大规模,跨国验证,以确认这些结果.
相关概念视频
Parkinson's Disease: Treatment
954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K


